UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes

Cancer, 2010-03, Vol.116 (5), p.1234-1242

2010

Volltextzugriff (PDF)

Association of Surgery With Improved Survival in Stage IV Breast Cancer Patients

Annals of surgery, 2008-05, Vol.247 (5), p.732-738

2008

Volltextzugriff (PDF)

Estrogen Receptor–Positive, Progesterone Receptor–Negative Breast Cancer: Association With Growth Factor Receptor Expression and Tamoxifen Resistance

JNCI : Journal of the National Cancer Institute, 2005-09, Vol.97 (17), p.1254-1261

2005

Volltextzugriff (PDF)

Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer

JNCI : Journal of the National Cancer Institute, 2000-04, Vol.92 (7), p.550-556

2000

Volltextzugriff (PDF)

Comparison of Fulvestrant Versus Tamoxifen for the Treatment of Advanced Breast Cancer in Postmenopausal Women Previously Untreated With Endocrine Therapy: A Multinational, Double-Blind, Randomized Trial

Journal of clinical oncology, 2004-05, Vol.22 (9), p.1605-1613

2004

Volltextzugriff (PDF)

HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: A Southwest Oncology Group Study

Clinical cancer research, 2004-09, Vol.10 (17), p.5670-5676

2004

Volltextzugriff (PDF)

Survival of patients with metastatic breast carcinoma: Importance of prognostic markers of the primary tumor

Cancer, 2003-02, Vol.97 (3), p.545-553

2003

Volltextzugriff (PDF)

BRCA1 deficiency in mature CD8+ T lymphocytes impairs antitumor immunity

Journal for immunotherapy of cancer, 2023-02, Vol.11 (2), p.e005852

2023

Volltextzugriff (PDF)

Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma : A prospectively planned combined survival analysis of two multicenter trials

Cancer, 2005-07, Vol.104 (2), p.236-239

2005

Volltextzugriff (PDF)

Patterns of Resistance and Incomplete Response to Docetaxel by Gene Expression Profiling in Breast Cancer Patients

Journal of clinical oncology, 2005-02, Vol.23 (6), p.1169-1177

2005

Volltextzugriff (PDF)

Adenoid cystic carcinoma of the breast: Molecular markers, treatment, and clinical outcome

Cancer, 2002-04, Vol.94 (8), p.2119-2127

2002

Volltextzugriff (PDF)

ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer

BMC medical genomics, 2020-05, Vol.13 (1), p.69-18, Article 69

2020

Volltextzugriff (PDF)

Ductal Lavage for Detection of Cellular Atypia in Women at High Risk for Breast Cancer

JNCI : Journal of the National Cancer Institute, 2001-11, Vol.93 (21), p.1624-1632

2001

Volltextzugriff (PDF)

Correction: Author Correction: Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis

Nature communications, 2018-03, Vol.9 (1), p.1-1, Article 16211

2018

Volltextzugriff (PDF)

Tumor Biologic Factors and Breast Cancer Prognosis Among White, Hispanic, and Black Women in the United States

JNCI : Journal of the National Cancer Institute, 1994-05, Vol.86 (9), p.705-712

1994

Volltextzugriff (PDF)

Tales from a targeted therapy

Journal of clinical oncology, 2006-03, Vol.24 (9), p.1323-1325

Elledge, Richard M

2006

Volltextzugriff (PDF)

Effects of Radiation Therapy on Breast Epithelial Cells in BRCA1/2 Mutation Carriers

Breast Cancer: Basic and Clinical Research, 2015-01, Vol.2015 (2015), p.25-29

2015

Volltextzugriff (PDF)

Phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.3158-3158

2024

Volltextzugriff (PDF)

Endocrine Therapy for Leptomeningeal Metastases from ER‐Positive Breast Cancer: Case Report and a Review of the Literature

The breast journal, 2016-03, Vol.22 (2), p.218-223

2016

Volltextzugriff (PDF)

Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary results

Clinical breast cancer, 2003-12, Vol.4 (5), p.348-353

2003

Volltextzugriff (PDF)

Abstract PS5-31: Molecular markers of response to s-equol, a novel oral estrogen receptor (ER) beta agonist for triple negative breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS5-31-PS5-31

2021

Volltextzugriff (PDF)

Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers

Breast cancer research and treatment, 2005-12, Vol.94 (3), p.279-284

2005

Volltextzugriff (PDF)

Primary breast cancer phenotypes associated with propensity for central nervous system metastases

Cancer, 2006-08, Vol.107 (4), p.696-704

2006

Volltextzugriff (PDF)

Novel estrogen receptor beta agonist S-equol decreases tumor proliferation in patients with triple negative breast cancer (TNBC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.560-560

2020

Volltextzugriff (PDF)

Association of radiotherapy with preferential depletion of luminal epithelial cells in a BRCA1 mutation carrier

Experimental hematology & oncology, 2012-10, Vol.1 (1), p.31-31, Article 31

2012

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(122)

Publikationsform

Sprache

Englisch
(135)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes

Association of Surgery With Improved Survival in Stage IV Breast Cancer Patients

Estrogen Receptor–Positive, Progesterone Receptor–Negative Breast Cancer: Association With Growth Factor Receptor Expression and Tamoxifen Resistance

Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer

Comparison of Fulvestrant Versus Tamoxifen for the Treatment of Advanced Breast Cancer in Postmenopausal Women Previously Untreated With Endocrine Therapy: A Multinational, Double-Blind, Randomized Trial

HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: A Southwest Oncology Group Study

Survival of patients with metastatic breast carcinoma: Importance of prognostic markers of the primary tumor

BRCA1 deficiency in mature CD8+ T lymphocytes impairs antitumor immunity

Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma : A prospectively planned combined survival analysis of two multicenter trials

Patterns of Resistance and Incomplete Response to Docetaxel by Gene Expression Profiling in Breast Cancer Patients

Adenoid cystic carcinoma of the breast: Molecular markers, treatment, and clinical outcome

ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer

Ductal Lavage for Detection of Cellular Atypia in Women at High Risk for Breast Cancer

Correction: Author Correction: Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis

Tumor Biologic Factors and Breast Cancer Prognosis Among White, Hispanic, and Black Women in the United States

Tales from a targeted therapy

Effects of Radiation Therapy on Breast Epithelial Cells in BRCA1/2 Mutation Carriers

Phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors

Endocrine Therapy for Leptomeningeal Metastases from ER‐Positive Breast Cancer: Case Report and a Review of the Literature

Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary results

Abstract PS5-31: Molecular markers of response to s-equol, a novel oral estrogen receptor (ER) beta agonist for triple negative breast cancer

Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers

Primary breast cancer phenotypes associated with propensity for central nervous system metastases

Novel estrogen receptor beta agonist S-equol decreases tumor proliferation in patients with triple negative breast cancer (TNBC)

Association of radiotherapy with preferential depletion of luminal epithelial cells in a BRCA1 mutation carrier

Aktive Filter

Suchergebnisse filtern